Moleculin Biotech, Inc. ( MBRX) - Stock Earnings
MBRX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 11, 2026, midnight | — / — | — | — / — | — |
MBRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -25.4 million USD | — USD |
| 2025Q4 | 15.6 million USD | — USD |
| 2026Q1 | -12.8 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
MBRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -29.8 million USD | — USD |
| 2024 | -21.8 million USD | — USD |
| 2025 | -33.6 million USD | — USD |
| 2026 Est. | — | — |
MBRX
Price: $2.12
52 week price:
Earnings Per Share: -28.42 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 14187
Ebitda: -2.9 millionMarket Capitalization: 14.1 million